Total Payments
$438,915
2024 Payments
$35,277
Companies
108
Transactions
3,213
Medicare Patients
8,221
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$328,999 (75.0%)
Food & Beverage$61,439 (14.0%)
Travel$34,942 (8.0%)
Consulting$12,868 (2.9%)
Education$667.50 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $325,344 | 211 | 74.1% |
| Food and Beverage | $61,439 | 2,850 | 14.0% |
| Travel and Lodging | $34,942 | 122 | 8.0% |
| Consulting Fee | $12,868 | 7 | 2.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,000 | 1 | 0.7% |
| Education | $667.50 | 20 | 0.2% |
| Honoraria | $640.00 | 1 | 0.1% |
| Entertainment | $15.29 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $166,018 | 289 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $95,529 | 255 | $0 (2022) |
| Amgen Inc. | $41,378 | 221 | $0 (2024) |
| Esperion Therapeutics, Inc. | $40,483 | 170 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $27,072 | 105 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $14,960 | 130 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $7,557 | 34 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $7,526 | 24 | $0 (2017) |
| ABBVIE INC. | $3,224 | 230 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,699 | 148 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35,277 | 390 | Amgen Inc. ($24,346) |
| 2023 | $20,672 | 408 | Amgen Inc. ($13,425) |
| 2022 | $21,100 | 427 | Esperion Therapeutics, Inc. ($13,466) |
| 2021 | $29,619 | 468 | Esperion Therapeutics, Inc. ($17,504) |
| 2020 | $15,022 | 342 | Esperion Therapeutics, Inc. ($4,089) |
| 2019 | $50,114 | 351 | Janssen Pharmaceuticals, Inc ($25,645) |
| 2018 | $79,540 | 344 | SANOFI-AVENTIS U.S. LLC ($41,671) |
| 2017 | $187,572 | 483 | Janssen Pharmaceuticals, Inc ($109,670) |
All Payment Transactions
3,213 individual payment records from CMS Open Payments — Page 1 of 129
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Central Nervous System | ||||||
| 12/30/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $8.12 | General |
| Category: PAIN | ||||||
| 12/23/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: Neurology | ||||||
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: Cardiology | ||||||
| 12/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/10/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Neurology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.78 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 12/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,069 | 5,561 | $869,036 | $346,620 |
| 2022 | 28 | 2,165 | 5,924 | $929,463 | $336,428 |
| 2021 | 25 | 1,646 | 4,164 | $421,964 | $211,804 |
| 2020 | 24 | 2,341 | 6,617 | $832,411 | $271,969 |
Total Patients
8,221
Total Services
22,266
Medicare Billing
$1.2M
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 15 | 22 | $2,347 | $902.00 | 38.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 16 | 19 | $2,166 | $777.52 | 35.9% |
| 97760 | Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | Office | 2022 | 19 | 19 | $1,984 | $607.64 | 30.6% |
| 99325 | New patient custodial care facility, group care, or assisted living visit, typically 30 minutes | Office | 2022 | 11 | 11 | $1,575 | $592.92 | 37.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 30 | 57 | $2,186 | $476.52 | 21.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 11 | 11 | $1,506 | $432.50 | 28.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 29 | 40 | $1,267 | $88.73 | 7.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 176 | 604 | $83,586 | $54,359 | 65.0% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 353 | 665 | $70,165 | $42,639 | 60.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 160 | 1,034 | $90,992 | $27,586 | 30.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 103 | 321 | $48,150 | $19,947 | 41.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 142 | 381 | $34,849 | $19,657 | 56.4% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 97 | 361 | $27,436 | $9,386 | 34.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 129 | 154 | $10,896 | $7,982 | 73.3% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2021 | 30 | 97 | $9,561 | $6,900 | 72.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 43 | 74 | $7,420 | $4,098 | 55.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 32 | 32 | $6,262 | $4,053 | 64.7% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 35 | 35 | $5,275 | $3,353 | 63.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 44 | 56 | $3,084 | $2,125 | 68.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 51 | 51 | $4,216 | $2,014 | 47.8% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 27 | 36 | $3,011 | $1,691 | 56.2% |
| 99326 | New patient assisted living visit, typically 45 minutes | Office | 2021 | 12 | 12 | $1,962 | $1,269 | 64.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,503 | $1,146 | 45.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2021 | 19 | 19 | $2,830 | $746.30 | 26.4% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2021 | 12 | 22 | $1,217 | $670.12 | 55.1% |
About Dr. John Richard, MD
Dr. John Richard, MD is a Family Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124047717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Richard, MD has received a total of $438,915 in payments from pharmaceutical and medical device companies, with $35,277 received in 2024. These payments were reported across 3,213 transactions from 108 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($325,344).
As a Medicare-enrolled provider, Richard has provided services to 8,221 Medicare beneficiaries, totaling 22,266 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Lexington, KY
- Active Since 07/18/2006
- Last Updated 01/13/2026
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124047717
Products in Payments
- XARELTO (Drug) $164,049
- SOLIQUA (Drug) $54,617
- NEXLIZET (Drug) $39,412
- Repatha (Biological) $38,738
- TOUJEO (Drug) $27,122
- ENTRESTO (Drug) $26,749
- Xtampza ER (Drug) $7,526
- SOLIQUA 100/33 (Drug) $7,481
- RELISTOR (Drug) $7,202
- LONHALA MAGNAIR (Drug) $6,934
- UTIBRON (Drug) $4,765
- SEEBRI (Drug) $2,128
- SOLIQUA 100/33 (Biological) $2,108
- CAPLYTA (Drug) $2,107
- TOUJEO (Biological) $1,996
- DISEASE STATE (Drug) $1,970
- REXULTI (Drug) $1,901
- VRAYLAR (Drug) $1,692
- NURTEC ODT (Drug) $1,475
- Ozempic (Drug) $1,386
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Lexington
Dr. Keith Stokes, Md, MD
Family Medicine — Payments: $550,575
Family Medicine $550,575
Dr. Susan Neil, Md, MD
Family Medicine — Payments: $23,499
Family Medicine $23,499
William Crigler, Md, MD
Family Medicine — Payments: $18,109
Family Medicine $18,109
Dr. Mark Weiser, Md, MD
Family Medicine — Payments: $12,183
Family Medicine $12,183
Dr. William Dacus, Md, MD
Family Medicine — Payments: $11,475
Family Medicine $11,475
Dr. William Korman, Md, MD
Family Medicine — Payments: $11,069
Family Medicine $11,069